TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

ECOG phase II trial of graded-dose peginterferon α-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602).

Ronald S Go et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.